Apyx Medical Announces Peer-Reviewed Clinical Publication Comparing The Use Of Renuvion To A Competing Technology Following Liposuction Or Body Contouring Procedures
Portfolio Pulse from Benzinga Newsdesk
Apyx Medical Corporation announced a peer-reviewed clinical publication demonstrating that its Renuvion technology results in significantly fewer adverse events compared to InMode's Bipolar RF system following liposuction or body contouring procedures. The study, published in Plastic and Reconstructive Surgery—Global Open, analyzed data from over 450 patients and found that Renuvion had a superior safety profile, shorter procedural times, and higher patient satisfaction rates.

August 08, 2024 | 10:08 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Apyx Medical's Renuvion technology demonstrated significantly fewer adverse events compared to InMode's Bipolar RF system in a clinical study, suggesting a safer alternative for post-liposuction or body contouring procedures.
The clinical study's findings highlight Renuvion's superior safety profile, which could lead to increased adoption and sales, positively impacting Apyx Medical's stock price.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100